DPX-RSV: Interim Phase I data

Interim data from a double-blind, placebo-controlled, Canadian Phase I trial in 40 healthy volunteers ages 50-64 showed that low- and high-dose intramuscular DPX-RSV led to antigen-specific antibody r...